Phoenix Holdings Ltd. Kura Oncology, Inc. Transaction History

Phoenix Holdings Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$11.78 - $16.98 $2 Million - $2.88 Million	-169,750 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$12.22 - $19.57 $64,155 - $102,742	-5,250 Reduced 3.0%	169,750 $2.38 Million
Q3 2021 Oct 27, 2021	BUY	$15.42 - $21.72 $1.23 Million - $1.74 Million	80,000 Added 84.21%	175,000 $3.28 Million
Q2 2021 Aug 10, 2021	BUY	$20.85 - $29.88 $1.98 Million - $2.84 Million	95,000 New	95,000 $1.98 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.